Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
McKesson
Julphar
Healthtrust
Johnson and Johnson
Deloitte
Farmers Insurance
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

Tridihexethyl chloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for tridihexethyl chloride and what is the scope of tridihexethyl chloride patent protection?

Tridihexethyl chloride
is the generic ingredient in one branded drug marketed by Lederle and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for tridihexethyl chloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Bulk Api Vendors: 12
Clinical Trials: 472
Patent Applications: 726
DailyMed Link:tridihexethyl chloride at DailyMed
Synonyms for tridihexethyl chloride
(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium chloride
(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium;chloride
(3-Cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammonium chloride
3-cyclohexyl-N,N,N-triethyl-3-hydroxy-3-phenylpropan-1-aminium chloride
4310-35-4
60-49-1 (Parent)
AC1L2FZ7
ACM4310354
AMMONIUM, (3-CYCLOHEXYL-3-HYDROXY-3-PHENYLPROPYL)TRIETHYL-, CHLORIDE
BENZENEPROPANAMINIUM, G-CYCLOHEXYL-N,N,N-TRIETHYL-G-HYDROXY-
Benzenepropanaminium, gamma-cyclohexyl-N,N,N-triethyl-gamma-hydroxy-, chloride
C21H36NO.Cl
CAS-4310-35-4
CCG-221042
CHEBI:9703
CHEMBL1200771
D00723
DSSTox_CID_3701
DSSTox_GSID_23701
DSSTox_RID_77155
DTXSID4023701
EINECS 224-323-3
HMS1571A06
HMS2098A06
HMS2233A09
HMS3373K12
LS-17260
MLS002154119
NCGC00017006-01
OR069671
OR293445
Pathilon (TN)
Pathilon chloride
SCHEMBL100471
SMR001233426
SR-01000838833
SR-01000838833-2
Tox21_110733
TRIDIHEXETHYL CHLORIDE (200 MG)
Tridihexethyl chloride (BAN)
Tridihexethyl chloride [BAN]
Tridihexethyl chloride [USP:INN:BAN]
Tridihexethyl chloride(200 mg)

US Patents and Regulatory Information for tridihexethyl chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle PATHILON tridihexethyl chloride INJECTABLE;INJECTION 009729-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle PATHILON tridihexethyl chloride TABLET;ORAL 009489-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Queensland Health
Express Scripts
Healthtrust
Dow
Federal Trade Commission
Mallinckrodt
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.